Trimetozine

From Wikipedia, the free encyclopedia
Trimetozine
Systematic (IUPAC) name
morpholin-4-yl-(3,4,5-trimethoxyphenyl)methanone
Clinical data
AHFS/Drugs.com International Drug Names
Legal status Prescription only
Routes Oral
Identifiers
CAS number 635-41-6
ATC code None
PubChem CID 12478
ChemSpider 11968
UNII 31EPT7G9PL YesY
ChEMBL CHEMBL1697853
Chemical data
Formula C14H19NO5 
Mol. mass 281.304 g/mol

Trimetozine (Opalene, Trimolide, Trioxazine) is a sedative that has been marketed in Europe since 1959.[1][2] It also has mild tranquilizing effects and has been used in the treatment of anxiety.[3][4] Its mechanism of action is unclear.[citation needed]

References

  1. Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. p. 1932. ISBN 3-88763-075-0. 
  2. David J. Triggle (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 0-412-46630-9. 
  3. Taverna P, Ferrari G (June 1970). "[Clinical trial of a new tranquilizing agent: trioxazine]". Minerva Medica (in Italian) 61 (46): 2574–90. PMID 5425739. 
  4. Shpak VM, Shcheglova AIu (August 1968). "[Trioxazine in the treatment of night anxiety in children]". Pediatriia (in Russian) 47 (8): 76–7. PMID 5730033. 
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.